
Vanda Pharmaceuticals Inc
NASDAQ:VNDA

Intrinsic Value
The intrinsic value of one
VNDA
stock under the Base Case scenario is
7.73
USD.
Compared to the current market price of 4.33 USD,
Vanda Pharmaceuticals Inc
is
Undervalued by 44%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Vanda Pharmaceuticals Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Vanda Pharmaceuticals Inc
Balance Sheet Decomposition
Vanda Pharmaceuticals Inc
Current Assets | 438.9m |
Cash & Short-Term Investments | 374.6m |
Receivables | 47.1m |
Other Current Assets | 17.1m |
Non-Current Assets | 217.3m |
PP&E | 12.7m |
Intangibles | 114.1m |
Other Non-Current Assets | 90.5m |
Free Cash Flow Analysis
Vanda Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Vanda Pharmaceuticals Inc
Revenue
|
198.8m
USD
|
Cost of Revenue
|
-11.3m
USD
|
Gross Profit
|
187.5m
USD
|
Operating Expenses
|
-228.1m
USD
|
Operating Income
|
-40.7m
USD
|
Other Expenses
|
21.8m
USD
|
Net Income
|
-18.9m
USD
|
VNDA Profitability Score
Profitability Due Diligence
Vanda Pharmaceuticals Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Score
Vanda Pharmaceuticals Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
VNDA Solvency Score
Solvency Due Diligence
Vanda Pharmaceuticals Inc's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Score
Vanda Pharmaceuticals Inc's solvency score is 72/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VNDA Price Targets Summary
Vanda Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
VNDA
is 12.92 USD
with a low forecast of 5.05 USD and a high forecast of 21 USD.
Dividends
Current shareholder yield for VNDA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
VNDA
stock under the Base Case scenario is
7.73
USD.
Compared to the current market price of 4.33 USD,
Vanda Pharmaceuticals Inc
is
Undervalued by 44%.